Latest News

• Drugmaker Insys Wins Bankruptcy Court Approval to Sell Off Opioid Drugmaker Insys Therapeutics Inc on Thursday won court approval to sell its flagship fentanyl spray to a buyer who agreed to only market the drug for use by cancer patients, in response to concerns about the product's role in fueling the opioid epidemic.
  Reuters Health Information, September 2019
• Unsafe Sex: Argentina Crisis Deflates Condom Sales as Costs Rise In South America's capital of romance, Argentine lovers are cutting back on one important cost: contraception.
  Reuters Health Information, September 2019
• Neurotoxin May Have Caused Diplomats' Illness in Cuba - Study Fumigation against mosquitoes in Cuba and not "sonic attacks" may have caused some 40 U.S. and Canadian diplomats and family members in Havana to fall ill, according to a new study commissioned by the Canadian government.
  Reuters Health Information, September 2019
• E-Sniffer Predicts Non-Responders to Lung Cancer Immunotherapy An electronic "nose" that detects chemicals in the breath of lung cancer patients may help distinguish between those who will and will not respond to immunotherapy, a new study suggests.
  Reuters Health Information, September 2019
• Strategies for Slowing Myopia Progression in Kids Differ Widely Between Ophthalmologists The strategies for slowing myopia progression differ widely among pediatric ophthalmologists around the world and include both effective and ineffective approaches, according to an online survey.
  Reuters Health Information, September 2019
• Acute Migraine Pain Relief With Oral Rimegepant Yields Lasting Benefits The acute treatment of migraine with rimegepant can provide lasting reduction in migraine-related disability and improved quality of life, according to new data presented earlier this month at the International Headache Conference (IHC) in Dublin, Ireland.
  Reuters Health Information, September 2019
• Alert EMA Panel Backs Netarsudil for Elevated Intraocular Pressure An EMA advisory panel recommended marketing authorization for netarsudil ophthalmic solution 0.02% for the treatment of adults with glaucoma or ocular hypertension.
  International Approvals, September 2019
• Alert EMA Panel Backs Anesthetic Spray for Premature Ejaculation Senstend, a spray containing lidocaine/prilocaine, can improve ejaculatory control and sexual satisfaction and reduce distress related to ejaculation, the EMA said.
  International Approvals, September 2019
• Alert EMA Panel Backs Belimumab for Children With Lupus An EMA panel recommended extending the indication for belimumab to children aged 5 years and older with systemic lupus erythematosus.
  International Approvals, September 2019
• Alert EU Panel Votes to Expand Dulaglutide Indication Based on REWIND The panel also recommends approval of Qtrilmet, a fixed-dose combination of metformin hydrochloride/saxagliptin/dapagliflozin for treatment of type 2 diabetes.
  International Approvals, September 2019
• ECTRIMS 2019MS Risk Nearly Doubles 15 Years Following Teen Concussion An association between concussion during adolescence and long-term, elevated risk for multiple sclerosis grew stronger with new evidence from a large study.
  Medscape Medical News, September 2019
• HFSA 2019Adding Patiromer Allows More Spironolactone in Resistant HTN, CKD With or without heart failure, add-on treatment with the potassium sequestrant 'enabled' more intensive use of the aldosterone blocker otherwise limited by hyperkalemia, according to the AMBER trial.
  Medscape Medical News, September 2019
• Alert FDA OKs Packaging for OTC Loperamide to Help Stem Misuse, Abuse The changes to Imodium A-D, Imodium Multi-Symptom Relief, and Be Health Loperamide HCl Capsules limit each carton to no more than 48 mg of loperamide and require unit-dose blister packaging.
  News Alerts, September 2019
• Alert FDA Expands Indications for Pifeltro and Delstrigo for HIV The FDA expanded the indications for the two HIV drugs to include appropriate patients with HIV-1 with virological suppression.
  FDA Approvals, September 2019
• New Drug Pricing Bill Allows Negotiation With Pharma Lawmakers are exploring ways to cut drug prices. Major changes in law may be unlikely near-term, but Congress might be able to take a step soon, like capping seniors' Medicare Part D contributions.
  Medscape Medical News, September 2019
• Trump Executive Order Aims to Speed Flu Vaccine Development The order creates a new task force charged with coming up with a 5-year plan.
  Medscape Medical News, September 2019
• Sandy Hook Shooting Victims' Advocacy Group Airs Chilling Anti-School Violence Ad Sandy Hook Promise, a non-profit organization led by family members of children massacred at a Connecticut elementary school in 2012, released a chilling public awareness advertisement for its violence prevention campaign on Wednesday.
  Reuters Health Information, September 2019
• Alert FDA OKs 'Game-Changer' Oral GLP-1 Agonist for Type 2 Diabetes Semaglutide is the first oral glucagon-like peptide-1 receptor agonist. Previously, drugs of this class were available only as injectables. The approval is expected to increase uptake.
  FDA Approvals, September 2019
• Alert New Option Soon for Some European Patients With Leukemia Gilteritinib has been recommended for approval for the treatment of adults with relapsed or refractory acute myeloid leukemia (AML) with an FLT3 mutation.
  International Approvals, September 2019
• Brutal Toll of Osteoporotic Fractures Revealed in New NOF Report Osteoporotic fractures are responsible for more hospitalizations than heart attacks, strokes, and breast cancer. "The biggest surprise...is that things are worse than we thought," says one expert.
  Medscape Medical News, September 2019